Word

EIKON

Status

Pending

Status Code

732

Status Date

Friday, January 19, 2024

Serial Number

90690436

Mark Type

4000

Filing Date

Tuesday, May 4, 2021

Published for Opposition

Tuesday, June 7, 2022

Trademark Owner History

EIKON THERAPEUTICS, INC. - Owner At Publication

Classifications

5 Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes

42 Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells

Trademark Events

Jan 23, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 19, 2024

Sou Extension 3 Granted

Jan 19, 2024

Sou Extension 3 Filed

Jan 19, 2024

Sou Teas Extension Received

Jul 25, 2023

Notice Of Approval Of Extension Request E-Mailed

Jul 21, 2023

Sou Extension 2 Granted

Jul 21, 2023

Sou Extension 2 Filed

Jul 21, 2023

Sou Teas Extension Received

Feb 4, 2023

Notice Of Approval Of Extension Request E-Mailed

Feb 2, 2023

Sou Extension 1 Granted

Feb 2, 2023

Sou Extension 1 Filed

Feb 2, 2023

Sou Teas Extension Received

Aug 2, 2022

Noa E-Mailed - Sou Required From Applicant

Jun 7, 2022

Official Gazette Publication Confirmation E-Mailed

Jun 7, 2022

Published For Opposition

May 18, 2022

Notification Of Notice Of Publication E-Mailed

May 4, 2022

Approved For Pub - Principal Register

May 4, 2022

Examiner's Amendment Entered

May 4, 2022

Notification Of Examiners Amendment E-Mailed

May 4, 2022

Examiners Amendment E-Mailed

May 4, 2022

Examiners Amendment -Written

May 4, 2022

Previous Allowance Count Withdrawn

May 4, 2022

Withdrawn From Pub - Managing Attorney Request

May 2, 2022

Approved For Pub - Principal Register

May 2, 2022

Examiner's Amendment Entered

May 2, 2022

Notification Of Examiners Amendment E-Mailed

May 2, 2022

Examiners Amendment E-Mailed

May 2, 2022

Examiners Amendment -Written

Jan 6, 2022

Notification Of Non-Final Action E-Mailed

Jan 6, 2022

Non-Final Action E-Mailed

Jan 6, 2022

Non-Final Action Written

Jan 5, 2022

Assigned To Examiner

Sep 13, 2021

Teas Change Of Correspondence Received

Sep 13, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 13, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 6, 2021

New Application Office Supplied Data Entered

May 7, 2021

New Application Entered